Karkinos Healthcare unveils Advanced Center for Cancer Diagnostics and Research in Kochi
Karkinos Healthcare has installed the most advanced high-throughput HPV assay equipment Cobas 6800 in this center with the ability to test over 1200 Human Papilloma Virus (HPV) assays of all high-risk types.
New Delhi: Karkinos Healthcare, a technology-driven, oncology focussed managed health care platform, has launched 'Advanced Center For Cancer Diagnostics and Research' in Kochi. The center was inaugurated by Hon'ble Chief Minister of Kerala, Shri. Pinarayi Vijayan.
Other dignitaries present at the event were: Shri. P. Rajeev, Hon'ble Minister for Industries, Law and Coir, Government of Kerala, Smt. Veena George, Hon'ble Minister for Health and Family Welfare, Government of Kerala and Prof. Mohanan Kunnummal, Vice-Chancellor, Kerala University of Health Sciences.
The Advanced Center for Cancer Diagnostics and Research will serve as a central lab for the Karkinos' global oncology network, analysing specimens at molecular and genomic level to aid in personalized targeted therapy, predicting possible response to treatment as well as to evaluate response by liquid biopsy.
While presenting the outline of the facility to the dignitaries, Dr. Moni Abraham Kuriakose, Co-Founder, Medical Director & CEO – Kerala Operations, Karkinos Healthcare said, "Advanced Center for Cancer Diagnostics and Research is the dedicated research lab for Karkinos Healthcare that strives to create solutions for the future through innovation. The focus is on early diagnostic tools, molecular assays for precision medicine, which are not readily available in the country. Karkinos Healthcare strives to create an India specific cancer genomic tumor panel and Support other clinicians, scientists and academic organization in various applied research programs."
Commenting on the occasion, Mr. Sundar Raman, Co-Founder of Karkinos Healthcare, said, "The estimated number of new cancer patients in India is 13.2 lakhs and existing number of cancer patients is three-times of this number. The catastrophe is that diagnoses are happening at late stage which is increasing the cost of treatment and lowering the cure rate. Karkinos attempts to bring synergy in distributed healthcare infrastructure through technology, so that cancer screening can be done at the community level and patient care becomes coordinated and seamless through the Karkinos Command Center. The vision of Karkinos Healthcare is to improve the cancer care experience and cure.
With the launch of the Advanced Center for Cancer Diagnostics and Research, we have added another crucial milestone in this journey – which will function as the central nervous system of the Karkinos Healthcare operations, spread across 12 states and growing exponentially."
Karkinos Healthcare has installed the most advanced high-throughput HPV assay equipment Cobas 6800 in this center with the ability to test over 1200 Human Papilloma Virus (HPV) assays of all high-risk types. Karkinos healthcare has partnered with professional organizations such as Kerala Federation of Obstetrics and Gynaecologic (KFOG).
Karkinos Healthcare has Ratan Tata, Venu Srinivasan, Kris Gopalakrishnan, Ronnie Screwvala, Vijay Shekar Sharma, and Bhavish Agarwal amongst its set of investors. The Tata Group is investing Rs. 110 crore in Karkinos while Rakuten Medical, the global clinical stage biotechnology company, Mayo Clinic and Reliance Digital Health, hold minority stakes. Venture Capital fund Endiya Partners also has a stake in the company.
Karkinos Healthcare is also setting up a Cancer Centre in Jawaharlal Nehru Institute of Medical Sciences (JNIMS) premises at Imphal, in partnership with the Government of Manipur.
Read also: Karkinos Healthcare launches HPV test CerviRaksha priced at Rs 2499
